The current valuation score of Aditxt Inc is 9.91, ranking 7 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is 0.00, which is +Inf% below the recent high of 0.01 and +Inf% above the recent low of -0.90.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.